Sabby Management, LLC 13F Portfolio

CIK 1535610 Filing since Q1 2014 Q2 2026 filed Aug 14, 2026
Holdings as of Jun 30, 2026, from the 13F filed Aug 14, 2026.

Portfolio Snapshot

4 positions · Q2 2026

Sabby Management, LLC reported 4 positions worth $4.46M for the quarter ended Jun 30, 2026, up 1,715.7% on the prior quarter. It opened 3 new positions, added to 0, trimmed 1 and exited 1. Its largest holding is TOYO Co., Ltd at 78.4% of the portfolio.

Portfolio Value
$4.46M
+1,715.7% QoQ · +35.7% YoY
Positions
4
3 new · 1 sold out
Top 10 Concentration
100%
of portfolio value
Largest Position
TOYO 78.4%
TOYO Co., Ltd
Net Buying
+$4.02M
$4.40M bought · $375.56K sold
Turnover
15.9%
of the portfolio traded
Top Sector
Industrials
81.2% of value
Track Record
49
quarters on file since Q1 2014

Portfolio Value & Positions

Value Positions

Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.

Sector Allocation

3 sectors
81.16%
Industrials
Industrials81.16%
Healthcare17.28%
Basic Materials1.56%

Quarterly Buying & Selling

Bought Sold

Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.

Position Changes

How many positions were opened, added to, trimmed or closed each quarter.

Sector Allocation Over Time

Share of reported value in each sector at every quarter end.

IndustrialsHealthcareBasic MaterialsTechnologyConsumer StaplesFinancial ServicesEnergyOtherConsumer DiscretionaryReal Estate

Largest Buys

Q2 2026
Holding Change Change % Trade Value Weight
TOYO TOYO Co., Ltd +503.8K – $3.50M 78.43%
CRVO CervoMed Inc. +248.9K – $771.53K 17.28%
SIDU Sidus Space Inc. +43.4K – $121.89K 2.73%

Largest Sells

Q2 2026
Holding Change Change % Trade Value Weight
INM InMed Pharmaceuticals Inc. -17.5K -79.6% $271.70K 1.56%
CLDI Calidi Biotherapeutics, Inc. -27.2K -100.0% $103.86K Exited

New Positions

Q2 2026
Holding Shares Trade Value Weight
TOYO TOYO Co., Ltd +503.8K $3.50M 78.43%
CRVO CervoMed Inc. +248.9K $771.53K 17.28%
SIDU Sidus Space Inc. +43.4K $121.89K 2.73%

Closed Positions

Q2 2026
Holding Shares Sold Trade Value Prior Weight
CLDI Calidi Biotherapeutics, Inc. -27.2K $103.86K 42.23%
Holdings · Q2 2026

4 Positions

As ofJun 30, 2026
Value$4.46M
Top 10100%
Avg position$1.12M
# Activity
Showing all 4 positions 13F filings on SEC EDGAR

Tip. Select a row to see that position’s full history at Sabby Management.

About Sabby Management, LLC’s 13F Portfolio

What are Sabby Management, LLC’s largest holdings?

As of its Q2 2026 13F filing, Sabby Management, LLC’s five largest positions were TOYO Co., Ltd (TOYO) at 78.4%, CervoMed Inc. (CRVO) at 17.3%, Sidus Space Inc. (SIDU) at 2.7%, InMed Pharmaceuticals Inc. (INM) at 1.6% of the reported portfolio.

How much is Sabby Management, LLC’s portfolio worth?

Sabby Management, LLC reported a 13F portfolio worth $4.46M across 4 positions for Q2 2026. That is up 1,715.7% from the previous quarter.

What did Sabby Management, LLC buy in Q2 2026?

Its largest purchases by value were TOYO Co., Ltd ($3.50M), CervoMed Inc. ($771.53K), Sidus Space Inc. ($121.89K). It opened 3 new positions.

What did Sabby Management, LLC sell in Q2 2026?

Its largest sales by value were InMed Pharmaceuticals Inc. ($271.70K), Calidi Biotherapeutics, Inc. ($103.86K). It exited 1 positions entirely.

Where does this data come from?

From the Form 13F-HR reports Sabby Management, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.

Similar-Sized Institutions

by reported 13F value

13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.